Funding for this research was provided by:
Seventh Framework Programme
José Carreras Leukämie-Stiftung
Medizinische Hochschule Hannover (MHH)
Received: 7 December 2022
Accepted: 26 December 2022
First Online: 13 January 2023
: The study was approved by the Institutional Review Board of Hannover Medical School, Hannover, Germany, and informed consent was obtained from patients and/or their guardians.
: None of the authors has a conflict of interest regarding the present study. The data presented here have not been previously presented and have not previously been submitted for publication in any other journal.